[WCN21;99;479]

MS In The Covid Era

Céline Louapre

I am particularly interested on bringing novel technical developments in MR imaging to investigate multiple sclerosis (MS) pathophysiological mechanisms with a particular emphasis to cortical pathology, quantitative markers of demyelination/remyelination and neuroinflammation.

Since 2015, I am medical coordinator of the Neuroscience Clinical Research Centre (CIC Neuroscience) at the Brain and Spine Institute (ICM), conducting more than 80 clinical trials in the field of Neuroscience.

Since 2018, I also coordinate together with Prof Gilles Edan (Rennes, FR) the national clinical research network for MS FCRIN4MS. In line with this experience in clinical research, my research work has been recently focused on developing translational clinical trials in remyelination strategies, and on developing multimodal approach to stratify cohorts of MS patients.

Since onset of COVID-19 pandemics, I initiated and coordinated the French registry COVISEP in order to characterize clinical outcomes and severity of COVID-19 in patients with MS.